NASDAQ · Medical Devices · USD

Adagio Medical Holdings, Inc. (ADGM) Stock Analysis

Adagio Medical Holdings, Inc. (ADGM) is a Medical Devices stock listed on NASDAQ and quoted in US Dollar.

Last Updated: October 21, 2026

ADGM

$0.12

−$0.01 (−4.55%)

Oct 21, 2026 · Market close

Compare

Price History

Hover for the daily close. The dotted line marks the period open.

Compare ADGM with… →

ADGM Key Statistics

As of Oct 21, 2026

Trading

Open: $0.12
Previous Close: $0.12
Day's Range: 0.11–0.12
52-Week Range: 0.083–1.69
Volume: 749.02K
Beta: 0.01

Valuation

Market Cap: $3.16M
P/E Ratio: unprofitable
EPS (ttm): −1.37

Financials (FY)

Revenue (FY): $0.00−100.00%
Net Income (FY): −$25.08M
Shares Outstanding: 27.44M
1-Year Return: −91.94%

Dividend and dates

Avg Volume: 9.62M

Only metrics the company reports are shown. Data provided by Yahoo Finance via yfinance. Updated daily.

Key facts

As of October 21, 2026, ADGM closed at $0.12, −91.94% over 1 year.

Adagio Medical Holdings, Inc. (ADGM) has a market capitalization of $3.16M.

In fiscal 2025, ADGM reported revenue of $0.00.

ADGM Stock Return by Calendar Year

Adagio Medical Holdings, Inc. (ADGM) return since Aug 2024: what $10,000 became

1 year: $10,000 $806; −91.94%
Since Aug 2024: $10,000 $127; −98.73%

If you had invested $10,000 in Adagio Medical Holdings, Inc. (ADGM) at the close on August 1, 2024, the earliest close on record here, it would have been worth $127 at the close on October 21, 2026: −98.73% in total, −85.98% a year, over a partial period shorter than 10 years. A historical calculation from closing prices adjusted for splits and dividends, before fees and taxes.

Calendar-year returns computed from daily closing prices. Partial years are shown muted and marked with an asterisk.

−88.40%−0.95%−88.91%

2024*20252026*

Year	Return
2026 (partial year)	−88.91%
2025	−0.95%
2024 (partial year)	−88.40%

As of October 21, 2026.

ADGM Revenue and Earnings by Fiscal Year

FY ends December

RevenueNet income

2021202220232025

Fiscal year	Revenue	Net income	Net margin
2025	$0.00	−$25.08M	—
2023	$300.00K	−$38.15M	−12,715.3%
2022	$189.00K	−$23.67M	−12,525.4%
2021	$270.00K	−$19.94M	−7,384.4%

Fiscal year	Revenue	Gross profit	Operating income	Net income	Net margin
2025	$0.00	−$684.00K	−$21.89M	−$25.08M	—
2023	$300.00K	−$1.01M	−$27.94M	−$38.15M	−12,715.3%
2022	$189.00K	−$686.00K	−$23.91M	−$23.67M	−12,525.4%
2021	$270.00K	−$888.00K	−$20.65M	−$19.94M	−7,384.4%

Annual figures as reported, in the company's reporting currency. As of December 31, 2025.

Recent News

News provided by third-party sources. Not financial advice.

Analysis

Data-derived

Company Overview

Adagio Medical Holdings, Inc. (ADGM) is capitalised at $3.16M on the latest close. It is classified in the Medical Devices industry, within the Healthcare sector. The company reports 41 employees.

Over the past 52 weeks the price has ranged from $0.083 to $1.69. The most recent close on file for ADGM is $0.12, dated October 21, 2026. That is −$0.01 (−4.55%) against the previous close. The latest close sits 38.92% above that 52-week low.

Financial Health

In fiscal 2025, Adagio Medical Holdings, Inc. reported revenue of $0.00. Against the prior fiscal year total of $300.00K, that is a change of −100.00%. The same year closed with a net loss of $25.08M. Earnings per share on a trailing basis come to −1.37.

Across the 4 fiscal years on file, revenue moves from $270.00K in 2021 to $0.00 in 2025. Of those 4 years, 0 report positive net income.

Valuation Assessment

The record shows negative trailing earnings, so no price-to-earnings ratio is published.

Over the trailing twelve months the total return is −91.94%. The stored price history starts on August 1, 2024, and the total return since then is −98.73%. Beta against the wider market is reported at 0.01. Daily returns over the trailing 2 years annualize to a volatility of 157.28%.

Growth & Income

The record shows no dividend for ADGM.

The record holds one complete calendar year, 2025, which returned −0.95%. So far in 2026 the total return is −88.91%.

Peer Comparison

Adagio Medical Holdings, Inc. (ADGM) operates in the Medical Devices industry. Here is how it compares to its closest peers by market capitalization:

Company	Ticker	Market Cap	P/E Ratio
Adagio Medical Holdings, Inc.	ADGM	$3.16M	—
Abbott Laboratories	ABT	$173.92B	32.4
Medtronic plc.	MDT	$119.00B	22.9
Stryker Corporation	SYK	$114.15B	30.8

The Medical Devices industry average P/E ratio is 27.1x. Adagio Medical Holdings, Inc. has no P/E ratio because it is not currently profitable.

Every figure above is read from this page's own data on each daily rebuild. Informational only, not financial advice. As of October 21, 2026.

Related Medical Devices Stocks

ABT

Abbott Laboratories

$173.92B

MDT

Medtronic plc.

$119.00B

SYK

Stryker Corporation

$114.15B

BSX

Boston Scientific Corporation

$64.33B

Edwards Lifesciences Corporation

$50.95B

GEHC

GE HealthCare Technologies Inc.

$31.17B

View all Medical Devices stocks →

Popular Healthcare Stocks

LLY

Eli Lilly and Company

$1.13T

JNJ

Johnson & Johnson

$621.22B

ABBV

AbbVie Inc.

$503.27B

UNH

UnitedHealth Group Incorporated

$374.30B

MRK

Merck & Co., Inc.

$369.78B

View all Healthcare stocks →

About Adagio Medical Holdings, Inc.

Adagio Medical Holdings, Inc., a medical technology company, focuses on the development and commercialization of ablation technologies for the treatment of cardiac arrhythmias. It offers treatment for cardiac arrhythmias, including atrial fibrillation, and ventricular tachycardia. The company's product portfolio includes iCLAS atrial ultra-low temperature ablation (ULTA) catheter and system; vCLAS ventricular ULTC catheter; and Cryopulse pulsed field cryoablation catheters. Adagio Medical Holdings, Inc. was founded in 2011 and is headquartered in Laguna Hills, California.

Visit website →